Cancer genetics and precision medicine

Rob Pieters, Chief Medical Officer (CMO) at Princess Máxima Center for Pediatric Oncology and Professor of Pediatric Oncology at the University of Utrecht (The Netherlands) Precision Medicine in the Princess Máxima Center for Pediatric Oncology

David Gisselsson Nord, Division of Clinical Genetics; Principal investigator at LUCC: Lund University Cancer Centre (Sweden) Implementing nationwide whole genome sequencing for all children with cancer in Sweden

Alwin Krämer, Full Professor at the University of Heidelberg, Director of the Clinical Cooperation Unit Molecular Hematology/Oncology of German Cancer Research Center (DKFZ), Department of Internal Medicine, University of Heidelberg (Germany) Precision oncology approaches in cancer of unknown primary (CUP)

Martin Zoche, director at Molecular Tumor Profiling,  Dept. of Pathology and Molecular Pathology, University Hospital Zurich and a Lecturer at the University of Zurich (Switzerland) Homologous Recombination Deficiency (HRD) Testing in Clinical Practice

Juha Kononen, Chief Clinical Director, Docrates Cancer Clinic (Finland) Precision oncology in clinical practice: successes and challenges

Jukka Kanerva, Consultant in pediatric hematology and oncology, New Children’s Hospital, Helsinki University Hospital and University of Helsinki (Finland) Pediatric precision medicine at Helsinki University Hospital

PMNET Forum 2022